Cargando…

OR10-2 Hormonal and Cardiometabolic Changes Associated with Diazoxide Choline Extended-Release (DCCR) Tablets in Patients with Prader-Willi Syndrome

BACKGROUND: Prader-Willi syndrome (PWS) is a rare genetic neurodevelopmental condition, characterized by hyperphagia, obesity, hormone deficiencies and behavioral/psychological manifestations. DCCR is under investigation as a treatment for hyperphagia in PWS through its actions on hypothalamic circu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abuzzahab, Jennifer, Angulo, Moris, Bird, Lynne, Butler, Merlin, Cowen, Neil, Gevers, Evelien, Goldstone, Anthony, Hirano, Patricia, Konczal, Laura, Lah, Melissa, Mathew, Verghese, Mejia Corletto, Jorge, Miller, Jennifer, Obrynba, Kathryn, Salehi, Parisa, Shaikh, M Guftar, Shoemaker, Ashley, Stevenson, David, Viskochil, David, Wilding, John, Woloschak, Michael, Yanovski, Jack, Felner, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Adipose Tissue, Appetite, & Obesity
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626988/ http://dx.doi.org/10.1210/jendso/bvac150.032

Ejemplares similares

RF24 | PSUN94 Long-Term Safety of Diazoxide Choline Extended-Release (DCCR) Tablets in Patients with Prader-Willi Syndrome
por: Woloschak, Michael, et al.
Publicado: (2022)

Diazoxide Choline Extended-Release Tablet in People With Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial
por: Miller, Jennifer L, et al.
Publicado: (2023)

MON-095 Phentermine Induces Weight Loss in Prader-Willi Syndrome
por: Mottalib, Adham, et al.
Publicado: (2019)

FRI082 Impact Of Setmelanotide On Metabolic Parameters And Vital Signs In Patients With Hypothalamic Obesity
por: Jennifer Abuzzahab, M, et al.
Publicado: (2023)

FRI066 Treatment History And Comorbidities Reported By Patients With Hypothalamic Obesity Treated With Setmelanotide In A Phase 2 Trial
por: Roth, Christian L, et al.
Publicado: (2023)

SAT656 Weight Reduction After 6 Months Of Setmelanotide Treatment In Patients With Hypothalamic Obesity
por: Roth, Christian L, et al.
Publicado: (2023)

SUN-597 Healthcare Utilization Patterns Among Commercially Insured Patients with Prader-Willi Syndrome: A Retrospective Analysis of Administrative Claims
por: Butler, Merlin G, et al.
Publicado: (2020)

FRI065 Trial Design Of A Double-blind, Randomized, Placebo-controlled, Phase 3 Study Of Setmelanotide In Patients With Hypothalamic Obesity
por: Roth, Christian L, et al.
Publicado: (2023)

MON-093 Myokine Levels after Resistance Exercise in Young Adults with Prader-Willi Syndrome (PWS)
por: Hirsch, Harry, et al.
Publicado: (2019)

SUN-604 U.S. Prevalence & Mortality of Prader-Willi Syndrome: A Population-Based Study of Medical Claims
por: McCandless, Shawn E, et al.
Publicado: (2020)

SUN-595 Comparative Comorbidity Burden Among Patients with Prader-Willi Syndrome: A Population-Level Cohort Study
por: Stafford, Diane E J, et al.
Publicado: (2020)

SUN-608 Juvenile Toxicity Study of Livoletide: A Peptide Analogue of Unacylated Ghrelin for the Treatment of Hyperphagia in Prader-Willi Syndrome
por: Xu, Howard, et al.
Publicado: (2020)

MON-102 Nonclinical Development of AZP-531 (Livoletide): A Peptide Analog of Unacylated Ghrelin for the Treatment of Hyperphagia in Prader-Willi Syndrome
por: Milano, Stephane, et al.
Publicado: (2019)

SUN-609 Livoletide (AZP-531), an Unacylated Ghrelin Analogue, Improves Hyperphagia and Food-Related Behaviors Both in Obese and Non-Obese People with Prader-Willi Syndrome
por: Harisseh, Rania, et al.
Publicado: (2020)

SAT-100 Trial-in-Progress: ZEPHYR, a Pivotal Phase 2b/3 Randomized, Placebo-Controlled Study of Livoletide, a Novel Unacylated Ghrelin Analog, for the Treatment of Hyperphagia and Food-Related Behaviors in Patients with Prader-Willi Syndrome
por: Allas, Soraya, et al.
Publicado: (2019)

FRI076 Colchicine Treatment Effects On The Gut Microbiome In Adults With Metabolic Syndrome, Insulin Resistance, And High C-reactive Protein (CRP): A Secondary Analysis Of A Randomized, Placebo-controlled Clinical Trial
por: Kisimba, Celine M, et al.
Publicado: (2023)

ODP606 Long-term Efficacy of Setmelanotide in Patients With Bardet-Biedl Syndrome
por: Argente, Jesús, et al.
Publicado: (2022)

LBODP003 Effects Of 4-weeks’ Treatment With Intraperitoneal Colchicine On Metabolic And Inflammatory Outcomes In Mice Fed A High-fat Diet
por: Arner, Brooke E, et al.
Publicado: (2022)

A Phase 3 Trial in Participants With Obesity Due to Bardet-Biedl Syndrome or Alström Syndrome: Efficacy and Safety of the Melanocortin 4 Receptor Agonist Setmelanotide
por: Haws, Robert, et al.
Publicado: (2021)

LBODP002 Phase II Open-label Pilot Trial Of Liraglutide In Adolescents With Obesity After Vertical Sleeve Gastrectomy: Interim Results From 8-weeks Of Treatment
por: Fatima, Syeda Z, et al.
Publicado: (2022)

Effects of Colchicine on Measures of Lipolysis in Adults With Obesity
por: Sarrafan-Chaharsoughi, Zahra, et al.
Publicado: (2021)

Impact of Semaglutide on Body Composition in Adults With Overweight or Obesity: Exploratory Analysis of the STEP 1 Study
por: Wilding, John P H, et al.
Publicado: (2021)

SAT-LB016 Diabetes and Non-Alcoholic Fatty Liver Disease in Two Patients with ROHHAD Syndrome
por: Sprague, Jennifer, et al.
Publicado: (2019)

Efficacy and Safety of Once-Weekly Subcutaneous Semaglutide 2.4 MG in Adults With Overweight or Obesity (STEP 1)
por: Wilding, John P H, et al.
Publicado: (2021)

SAT-LB107 Insulin Sensing by Astrocytes Is Critical for Normal Thermogenesis and Body Temperature Regulation
por: Hill, Jennifer Wootton, et al.
Publicado: (2020)

SUN-102 Spexin Differentially Regulates Adipogenesis in Brown and White Adipose Tissue Depots
por: Sherman, Shermel, et al.
Publicado: (2019)

MON-111 Amenorrhea In Exercising Women Is Associated With A Greater Reduction In Post-prandial Ghrelin
por: Koltun, Kristen, et al.
Publicado: (2019)

A randomized pilot efficacy and safety trial of diazoxide choline controlled-release in patients with Prader-Willi syndrome
por: Kimonis, Virginia, et al.
Publicado: (2019)

Skeletal Muscle Stromal Cells Derived From MuRF1 Knockout Mice Are Resistant to Adipogenesis
por: Norman, Jennifer Elise, et al.
Publicado: (2021)

The Effects of Diet Induced Obesity (DIO) on Skeletal Muscle Transcription in MuRF1 KO Mice
por: Marshall, Andrea Gail, et al.
Publicado: (2021)

RF12 | PSUN105 Cord Blood Leptin and Childhood Adiposity Outcomes in the Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study
por: DeLacey, Sean, et al.
Publicado: (2022)

Morbid Obesity Is Associated With Worse Outcomes and Increased Inpatient Mortality in Patients With Alcohol Induced Acute Pancreatitis
por: Shaka, Hafeez, et al.
Publicado: (2021)

SAT-094 Overweight and Obesity Associated with Immune-Related Adverse Events in Patients on Immune Checkpoint Inhibitor Therapy
por: Leiter, Amanda, et al.
Publicado: (2019)

Impact of Morbid Obesity on Patients With Hypertriglyceridemia Induced Acute Pancreatitis
por: Pudasaini, Garima, et al.
Publicado: (2021)

Morbid Obesity Does Not Impact Mortality, Rate of Endoscopy in Patients With Biliary Acute Pancreatitis: A US Nationwide Analysis
por: Shaka, Hafeez, et al.
Publicado: (2021)

Endocrine and Metabolic Comorbidities in Hospitalized Psoriasis Patients in the United States
por: Edigin, Ehizogie, et al.
Publicado: (2021)

SAT-093 Effect of HIV Infection and Antiretroviral Therapy Use on Body Weight and Body Weight Changes over a 5-Year Period in US Veterans
por: Garcia, Jose, et al.
Publicado: (2019)

OR10-1 Body Mass Index and Weight Reductions in Patients With Obesity Due to Heterozygous Variants in POMC, PCSK1, and LEPR After 1 Year of Setmelanotide
por: Farooqi, Sadaf, et al.
Publicado: (2022)

Obesity Is Associated With Higher odds of Hepatorenal syndrome in Patients Admitted With Alcoholic Hepatitis: Analysis of the National Inpatient Sample (2016–2017)
por: Asotibe, Jennifer Chiagoziem, et al.
Publicado: (2021)

Metabolic and Endocrine Comorbidities in Hidradenitis Suppurativa: A Nationwide Study
por: Edigin, Ehizogie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4gierc6r9286o9lmj18c4p3cbt